Skip to main content

Mobile Main Navigation

  • About
    • Background
    • Leadership
    • Scientific and Programmatic Support
    • Grantees
  • Grants & Resources
    • Grants & Resources
    • Types of Grants
    • How to Apply
  • Harvard Resources
  • Projects

Mobile Utility Navigation

  • Harvard Medical School
  • MyHMS
Menu

Utility Navigation

  • Harvard Medical School
  • MyHMS
Search

Main navigation

  • About
    • Background
    • Leadership
    • Scientific and Programmatic Support
    • Grantees
  • Grants & Resources
    • Grants & Resources
    • Types of Grants
    • How to Apply
  • Harvard Resources
  • Projects

Q-FASTR Records

Filter Q-FASTR Records

Filter Records
Fiscal Year Awarded
Funding Level
View as cardsView as table

Developing a Biomarker of Homologous Recombination Deficiency for Enhanced PARP Inhibitor Efficacy Across Cancers

Fiscal Year Awarded:

2025

Principal Investigator:

Peter Park

Developing a synthetic biology platform for pharmaceutical biomanufacturing

Fiscal Year Awarded:

2025

Principal Investigator:

Pamela Silver

Development of allosteric activators for immunotherapy

Fiscal Year Awarded:

2025

Principal Investigator:

Stephen Blacklow

Development of small molecule inhibitors of a gut bacterial metabolic toxin

Fiscal Year Awarded:

2025

Principal Investigator:

Sloan Devlin

In vivo gene editing to treat inherited Collagen VI-related myopathies

Fiscal Year Awarded:

2025

Principal Investigator:

Amy Wagers

In vivo strategy to induce tolerance to therapeutic proteins and autoantigens

Fiscal Year Awarded:

2025

Principal Investigator:

Amy Wagers

Investigating the mode of action of a highly selective insecticide and suitability for Anopheles management

Fiscal Year Awarded:

2025

Principal Investigator:

Norbert Perrimon

Oral pan-coronavirus anti-viral

Fiscal Year Awarded:

2025

Principal Investigator:

Timothy Mitchison

Structure-based discovery of chromatin remodeling inhibitors

Fiscal Year Awarded:

2025

Principal Investigator:

Lucas Farnung

Targeting cancers by de-repressing nuclear PDC

Fiscal Year Awarded:

2025

Principal Investigator:

David Scadden

  • Load More
Harvard Medical School
Facebook twitter linkedin instagram youtube

401 Park Drive
Suite 505
Boston, MA 02215
(617) 384-8500

Footer

  • Accessibility
  • Digital Accessibility​

User account menu

  • Log in

© 2025 by the President and Fellows of Harvard College